Is Dyne Therapeutics, Inc. (DYN) a Buy, Sell, or Hold?
NASDAQ : DYN
Dyne Therapeutics, Inc.
$23.74 USD
$1.02 (4.49%)
- Volume
- 1.54M
- Average Volume
- 1.84M
- Market Capitalization
- $3.92B
- P/E Ratio
- -7.37
- Dividend Yield
- 0.00%
- Price Target
- $35.50
- Year High
- $25.00
- Year Low
- $8.88
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.92
Analyst Consensus Summary
Consensus Rating
Sell
14 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-33.1%
vs Current Price
Price Target
$35.50
Average TargetPrice Target Range
Lowest Target
$24.00
-1.1% DOWNSIDE
Average Target
$35.50
Median Estimate
Highest Target
$47.00
-49.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 14
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 1 | 11 | 2 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Chardan Capital | Keay Nakae | $38 | $16.15 | 2026-03-02 05:37 PM | 135.3% |
| Morgan Stanley | Michael E Ulz | $47 | $15.68 | 2026-03-02 11:12 AM | 199.7% |
| Evercore ISI | Gavin Clark-Gartner | $36 | $19.5135 | 2025-12-15 08:38 AM | 84.5% |
| Tudor Pickering | William Pickering | $23 | $19.09 | 2025-12-09 07:40 AM | 20.5% |
| Morgan Stanley | Michael E Ulz | $50 | $22.2 | 2025-12-08 12:06 PM | 125.2% |